Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1145020190360020080
Journal of Acupuncture Research
2019 Volume.36 No. 2 p.80 ~ p.87
Atopic Dermatitis-Related Inflammation in Macrophages and Keratinocytes: The Inhibitory Effects of Bee Venom
Kim Deok-Hyun

Song Ho-Sueb
Abstract
Background: This study investigated the anti-inflammatory effects of bee venom (BV) through the inhibition of nuclear factor kappa beta (NF-¥êB) expression in macrophages and keratinocytes.

Methods: Cell viability assays were performed to investigate the cytotoxicity of BV in activated macrophages [lipopolysaccharide (LPS)] and keratinocytes [interferon-gamma/tumor necrosis factor-alpha (IFN-¥ã/TNF-¥á)]. A luciferase assay was performed to investigate the cellular expression of NF-¥êB in relation to BV dose. The expression of NF-¥êB inhibitors (p-I¥êB¥á, I¥êB¥á, and p50 and p65) were determined by Western Blot analysis, and the electromobility shift assay. A nitrite quantification assay was performed to investigate the effect of BV, and NF-¥êB inhibitor on nitric oxide (NO) production in macrophages. In addition, Western Blot analysis was performed to investigate the effect of BV on the expression of mitogen-activated protein kinases (MAPK) in activated macrophages and keratinocytes.

Results: BV was not cytotoxic to activated macrophages and keratinocytes. Transcriptional activity of NF-¥êB, and p50, p65, and p-I¥êB¥á expression was reduced by treatment with BV in activated macrophages and keratinocytes. Treatment with BV and an NF-¥êB inhibitor, reduced the production of NO by activated macrophages, and also reduced NF-¥êB transcriptional activity in activated keratinocytes (compared with either BV, or NF-¥êB inhibitor treatment). Furthermore, BV decreased p38, p-p38, JNK, and p-JNK expression in LPS-activated macrophages and IFN-¥ã/TNF-¥á-activated keratinocytes.

Conclusion: BV blocked the signaling pathway of NF-¥êB, which plays an important role in the inflammatory response in macrophages and keratinocytes. These findings provided the possibility of BV in the treatment of atopic dermatitis.
KEYWORD
atopic dermatitis, bee venom, inflammation, transcription factor
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)